An independent Data Monitoring Committee offers endorsed escalating to the second dose level, 400 mg bid, which cohort is now open for enrollment. Anadys expects to initiate dosing in this cohort in January 2010. Related StoriesOncolytic viral therapy authorized in the U.S. For use against late-stage melanomaUC Irvine Wellness researchers develop one-step check to detect HCV infectionsMedStar Washington Hospital Center's Ebola Response Team recognized with 2015 Patient Security Award We are very pleased with the 4-week antiviral response and safety because of this first dose cohort, said Steve Worland, Ph.D., President and CEO. We look forward to the forthcoming 12-week data, including antiviral response referred to as cEVR, for the 200 mg bid cohort in the 1st quarter of 2010 as well as RVR and cEVR data for the 400 mg bid cohort in the next quarter of 2010.Either method is appropriate treatment for the broken collarbone. Patients will become instructed to wear the sling at all times until there is no further discomfort with movement. This is usually 2 to four weeks for children and 4 to eight weeks for adults. Commercially obtainable slings could also be used. A cast or brace isn’t necessary. Patients may also be instructed to avoid the potential for additional trauma during this time period. Some patients may take OTC pain medicine, but others may necessitate a prescription pain medicine. Follow-up with a health-care professional before patient is pain free; a few patients may require some rehabilitation.